AntoXa

Life-saving biodefense solutions

  • About Us
    • Management Team
  • Products
  • Investors
  • News
  • Contact
You are here: Home / Management Team / Ron Hosking

Ron Hosking

November 29, 2018

Ron Hosking, CPA, CA

Mr. Ron Hosking, CPA, CA, is a chartered accountant with three decades of experience as a financial manager in the biotechnology and pharmaceutical industries. He is Chief Financial Officer of AntoXa Corporation and Chair of AntoXa’s Board of Directors.

Mr. Hosking is also a founder of PlantForm Corporation and PlantForm’s Chief Financial Officer.

From 1997 to 2008, Mr. Hosking was Vice-President Finance & Chief Financial Officer for PreMD Inc., a developer of point-of-care medical devices. He guided the company through seven public financings and onto the TSX (2000) and AMEX (2002) stock exchanges. He also helped negotiate out-licensing partnerships with McNeil Consumer Healthcare and AstraZeneca.

Mr. Hosking has also served as Vice-President Finance & CFO, LifeTECH Corporation; General Manager & CFO, Biomira Diagnostics Inc.; and Director of Marketing & Finance, Ortho Diagnostic Systems Inc. (Johnson & Johnson).

He is a member of Life Sciences Ontario and the Ontario Biosciences Innovation Organization.

Filed Under: Management Team

Latest News

AntoXa and SwiftPharma to present plant-made anti-ricin antibody technology to NATO expert panel

August 14, 2024

GUELPH, Ont., Canada, August 14, 2024 — AntoXa Corporation, a Canadian ...
Read more >

New Patent for AntoXa’s Plant-Made Anti-Ricin Antibody Manufacturing Process

January 30, 2024

GUELPH, Ont., Canada, January 30, 2024 — The Canadian Intellectual ...
Read more >

AntoXa Corporation and SwiftPharma Sign Exclusive Collaboration Agreement to Support the Development and Commercialization of a Plant-Made Antibody Against Ricin Exposure

September 5, 2023

GHENT, Belgium and TORONTO, Canada, September 5, 2023 – AntoXa ...
Read more >

About Us

Plant-made biopharmaceuticals for a safer world. AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally ...
Read more >

Global Demand for Biodefense Therapeutics

Governments are investing billions of dollars preparing for potential bioterrorism attacks and ...
Read more >

Subscribe to our Newsletter

vivoXPRESS® MANUFACTURING SYSTEM
The plant-based vivoXPRESS® manufacturing platform offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals. Here’s how it works.

BioPharming Info Centre

Biopharming, also known as plant molecular farming, refers to the use of genetically modified plants to produce a wide range of pharmaceuticals and industrial products. See our Biopharming Info Centre to Learn more about the science and history of using plants to produce complex therapeutic proteins.

Copyright © 2025 · AntoXa Corporation | Site by Curry Gunn & Associates